Milanez, Fernanda Manente <br/><br/>
IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients.  [electronic resource] 

 -  Arthritis research & therapy  Feb 2016 
 - 52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/s13075-016-0949-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antirheumatic Agents--therapeutic use<br/>Cross-Sectional Studies<br/>Dinoprostone--blood<br/>Disease Progression<br/>Female<br/>Humans<br/>Interleukin-17<br/>Interleukin-23--blood<br/>Male<br/>Middle Aged<br/>Spondylitis, Ankylosing--drug therapy<br/>Th17 Cells--drug effects<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors